Author

Sebastian Bothe

University of WürzburgORCID 0000-0001-6408-6112Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Ancély Ferreira dos SantosiD· 1 shared Apoorva MathuriD· 1 shared Ariane Nunes‐AlvesiD· 1 shared Bárbara MorgadoiD· 1 shared Bettina PronethiD· 1 shared Biplab GhoshiD· 1 shared Camilo A. Aponte-SantamariaiD· 1 shared Florêncio Porto FreitasiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

Ancély Ferreira dos SantosORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryeLifePeer-reviewedFeb 9, 2026

Aggregation-Dependent Epitope Sequence and Modification Fingerprints of Anti-Aβ Antibodies

Ivan Talucci, Timon Leske, Hans‐Wolfgang Klafki…·Hans Michael Maric

This study characterizes the binding and modification requirements of 20 anti-Aβ antibodies across different Aβ forms, revealing aggregation-dependent sequence and modification selectivity.

3 citationstop 2%

humanproteomics

𝕏 PostBluesky

Cell BiologybioRxivAug 5, 2025

Riboflavin metabolism shapes FSP1-driven ferroptosis resistance

Vera Skafar, Izadora de Souza, Biplab Ghosh…·José Pedro Friedmann Angeli

This study identifies riboflavin as a modulator of ferroptosis sensitivity by supporting FSP1 stability and antioxidant recycling, with implications for therapeutic targeting.

DOI 10.1038/s41556-025-01856-x

humangenetic perturbation / CRISPR

𝕏 PostBluesky